£1.5bn Tax Bill
Drug giant plans court challenge against tax authorities in long-running dispute over profit allocation, writes Rosie Murray-West
Glaxo Smithkline, the drug giant, yesterday revealed that it had received a £1.5billion bill from the US tax authorities and estimated it could also owe £1.4 billion in interest unless it wins a case against them
